Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
31.20
+0.04 (0.13%)
At close: Dec 5, 2025, 4:00 PM EST
30.69
-0.51 (-1.63%)
After-hours: Dec 5, 2025, 7:56 PM EST

Arcutis Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Market Capitalization
3,8221,6303059011,0431,225
Upgrade
Market Cap Growth
223.61%434.82%-66.18%-13.58%-14.88%-
Upgrade
Enterprise Value
3,7441,5082836266811,039
Upgrade
Last Close Price
31.2013.933.2314.8020.7428.13
Upgrade
PS Ratio
12.408.305.11244.56--
Upgrade
PB Ratio
23.7410.353.444.303.504.53
Upgrade
P/TBV Ratio
26.7811.013.714.453.504.53
Upgrade
EV/Sales Ratio
11.787.674.75169.88--
Upgrade
Debt / Equity Ratio
0.720.702.320.970.260.02
Upgrade
Asset Turnover
0.790.570.150.01--
Upgrade
Inventory Turnover
1.751.380.48---
Upgrade
Quick Ratio
3.073.726.3811.0611.6112.61
Upgrade
Current Ratio
3.504.147.0811.5712.0912.96
Upgrade
Return on Equity (ROE)
-28.17%-113.76%-175.79%-122.80%-72.62%-72.93%
Upgrade
Return on Assets (ROA)
-5.91%-23.25%-38.12%-43.97%-36.55%-42.14%
Upgrade
Return on Capital (ROIC)
-7.51%-28.52%-42.64%-47.89%-39.67%-45.26%
Upgrade
Return on Capital Employed (ROCE)
-14.10%-47.90%-81.80%-73.30%-55.10%-49.60%
Upgrade
Earnings Yield
-1.16%-8.59%-85.99%-34.55%-19.78%-11.07%
Upgrade
FCF Yield
-0.87%-6.89%-81.18%-28.63%-16.84%-9.25%
Upgrade
Buyback Yield / Dilution
-11.93%-74.53%-25.94%-11.39%-38.52%-1835.11%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.